收稿日期: 2018-05-02
网络出版日期: 2018-12-18
基金资助
国家自然科学基金(81571779)
Preparation and evaluation of blank and doxorubicin loaded poly (acrylic acid) microspheres for embolization
Received date: 2018-05-02
Online published: 2018-12-18
Supported by
Supported by the National Natural Science Foundation of China(81571779)
目的: 研究离子交换型载阿霉素聚丙烯酸栓塞微球的制备方法与性质评价。方法: 采用反相悬浮聚合法制备空白聚丙烯酸栓塞微球[poly (acrylic acid) microspheres,PMs],通过离子交换原理将阿霉素载入该微球,制备载阿霉素的聚丙烯酸栓塞微球[doxorubicin-loaded poly (acrylic acid) microspheres,DPMs]。采用光学显微镜考察两种微球的形态和粒径分布,荧光显微镜和激光扫描共聚焦显微镜考察载药微球中阿霉素的分布,物性测定仪测定PMs和DPMs的弹性,HPLC法测定PMs的载药性质和DPMs的释药性质。以0.1 mL的DPMs栓塞家兔肝动脉评价其在动物体内的栓塞效果。结果: 制备的PMs和DPMs形态圆整、表面光滑,能够均匀分散,阿霉素主要分布在靠近微球表面的区域且分布均匀。PMs和DPMs的平均粒径分别为(283±136) μm和(248±149) μm,杨氏模量分别为(62.63±1.65) kPa和(93.94±1.10) kPa,空白和载药微球均具有良好的抗压缩能力。PMs在12 h时达到载药平衡,包封率大于99%,在浓度为5.0 g/L和12.5 g/L的阿霉素溶液中微球的载药量分别为(19.78±0.27) g/L和(49.45±0.37) g/L;DPMs在磷酸盐缓冲液(phosphate buffered saline,PBS)中缓慢释放阿霉素,载药量为(19.78±0.27) g/L和(49.45±0.37) g/L的微球24 h体外累积释放百分数分别为6.82%±0.02%和2.83%±0.10%。影像学结果显示,DPMs成功地栓塞了家兔的肝动脉。结论: 聚丙烯酸微球具有良好的载阿霉素性能,DPMs是一种潜在的可用于动脉化疗栓塞的新型药物递送系统。
郭李盈 , 刘晓昕 , 李子圆 , 覃小雅 , 范则杨 , 李真真 , 关海涛 , 宋莉 , 邹英华 , 范田园 . 空白及载阿霉素的聚丙烯酸栓塞微球的制备与评价[J]. 北京大学学报(医学版), 2018 , 50(6) : 1070 -1077 . DOI: 10.3969/j.issn.1671-167X.2018.06.023
Objective: To prepare ion exchange doxorubicin-loaded poly (acrylic acid) microspheres (DPMs) and evaluate the properties of these chemoembolic agents.Methods:Poly (acrylic acid) microspheres (PMs) without drug were prepared by inverse suspension polymerization method and then doxorubicin was loaded by ion exchange mechanism to prepare DPMs. Optical microscope was used to investigate the morphology and particle size distribution of PMs and DPMs; fluorescence microscope and confocal microscope were used to observe the distribution of doxorubicin after drug loading. Elasticities of both the microspheres were evaluated by texture analyzer. High performance liquid chromatography (HPLC) method was established to determine the drug loading behavior of PMs and releasing behavior of DPMs. The in vivo embolic property was evaluated by embolizing the hepatic artery of a rabbit with 0.1 mL of DPMs.Results:PMs and DPMs were both spherical in shape, smooth in surface and dispersed well. Doxorubicin was mainly in the outer area inside of DPMs and distributed evenly. The average particle size of PMs and DPMs were (283±136) μm and (248±149) μm, respectively. PMs and DPMs both had good compression ability with the Young’s modulus of (62.63±1.65) kPa and (93.94±1.10) kPa separately. PMs reached the drug loading balance at 12 h, and the entrapment efficiency was greater than 99%. Drug loading of PMs in doxorubicin solution at the concentration of 5.0 g/L and 12.5 g/L was (19.78±0.27) g/L and (49.45±0.37) g/L, respectively. Doxorubicin released slowly from DPMs in PBS and the accumulative release percentages of DPMs with corresponding drug loading were 6.82%±0.02% and 2.83%±0.10% after 24 h, respectively. Arterial angiograms showed that the hepatic artery of the rabbit was successfully embolized with DPMs.Conclusion:DPMs with good performance of loading doxorubicin could be a potential embolic agent for transcatheter arterial chemoembolization.
Key words: Microspheres; Chemoembolization; therapeutic; Ion exchange; Doxorubicin; Sustained release
| [1] | 赵成如, 史文红, 金刚 . 医用介入栓塞材料[J]. 中国医疗器械信息, 2007,13(8):1-6. |
| [2] | 金雪锋, 许颖, 沈晓兰 , 等. 载药动脉栓塞微球DC Bead TM研究进展 [J]. 药学与临床研究, 2012,20(4):319-325. |
| [3] | Gomes AS, Monteleone PA, Sayre JW , et al. Comparison of triple-drug transcatheter arterial chemoembolization (TACE) with single-drug TACE using doxorubicin-eluting beads: long-term survival in 313 patients[J]. AJR Am J Roentgenol, 2017,209(4):722-732. |
| [4] | Verret V, Namur J, Ghegediban SH , et al. Toxicity of doxorubicin on pig liver after chemoembolization with doxorubicin-loaded microspheres: a pilot DNA-microarrays and histology study[J]. Cardiovasc Intervent Radiol, 2013,36(1):204-212. |
| [5] | Namur J, Pascale F, Maeda N , et al. Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC Bead in a model of VX2 liver metastases in the rabbit[J]. J Vasc Interv Radiol, 2015,26(7):1067-1075. |
| [6] | Kaiser J, Kr?mer I . Loading profile of topotecan into polyvinyl alcohol microspheres (DC Bead TM) over a 7-day period [J]. J Oncol Pharm Pract, 2012,18(2):222-228. |
| [7] | Fuchs K, Bize PE, Dormond O , et al. Drug-eluting beads loaded with antiangiogenic agents for chemoembolization: in vitro sunitinib loading and release and in vivo pharmacokinetics in an animal mo-del[J]. J Vasc Interv Radiol, 2014,25(3):379-387. |
| [8] | Cui DC, Lu WL, Sa EA , et al. Poly (acrylic acid) microspheres loaded with lidocaine: preparation and characterization for arterial embolization[J]. Int J Pharm, 2012,436(1-2):527-535. |
| [9] | Omidian H, Zohuriaan-Mehr MJ, Bouhendi H . Polymerization of sodium acrylate in inverse-suspension stabilized by sorbitan fatty esters[J]. Eur Polym J, 2003,39(5):1013-1018. |
| [10] | Lewis AL, Gonzalez MV, Leppard SW , et al. Doxorubicin eluting beads-1: effects of drug loading on bead characteristics and drug distribution[J]. J Mater Sci Mater Med, 2007,18(9):1691-1699. |
| [11] | Ahnfelt E, Sj?gren E, Hansson P , et al. In vitro release mechanisms of doxorubicin from a clinical bead drug-delivery system[J]. J Pharm Sci, 2016,105(11):3387-3398. |
| [12] | Laurent A . Microspheres and nonspherical particles for embolization[J]. Tech Vasc Interv Radiol, 2007,10(4):248-256. |
| [13] | Bendszus M, Klein R, Burger R , et al. Efficacy of trisacryl gela-tin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas[J]. AJNR Am J Neuroradiol, 2000,21(2):255-261. |
| [14] | Chua GC, Wilsher M, Young MP , et al. Comparison of particle penetration with non-spherical polyvinyl alcohol versus trisacryl gelatin microspheres in women undergoing premyomectomy uterine artery embolization[J]. Clin Radiol, 2005,60(1):116-122. |
| [15] | Hu FQ, Liu LN, Du YZ , et al. Synjournal and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide po-lymeric micelles[J]. Biomaterials, 2009,30(36):6955-6963. |
| [16] | Weng L, Le HC, Lin J , et al. Doxorubicin loading and eluting characteristics of bioresorbable hydrogel microspheres: in vitro study[J]. Int J Pharm, 2011,409(1):185-193. |
| [17] | Flandroy P, Grandfils C, Collignon J , et al.( D, L) polylactide microspheres as embolic agent. A preliminary study[J]. Neuroradiology, 1990,32(4):311-315. |
| [18] | Golzarian J, Weng L . Particle embolization: factors affecting arterial distribution[J]. J Vasc Interv Radiol, 2014,25(11):1773-1774. |
| [19] | Guiu B, Schmitt A, Reinhardt S , et al. Idarubicin-loaded ONCOZENE drug-eluting embolic agents for chemoembolization of hepatocellular carcinoma: In vitro loading and release and in vivo pharmacokinetics[J]. J Vasc Interv Radiol, 2015,26(2):262-270. |
| [20] | De BT, Plotkin S, Yu R , et al. An in vitro evaluation of four types of drug-eluting microspheres loaded with doxorubicin[J]. J Vasc Interv Radiol, 2016,27(9):1425-1431. |
| [21] | Brown KT . Re: Fatal pulmonary complications after arterial embolization with 40-120 microm tris-acryl gelatin microspheres[J]. J Vasc Interv Radiol, 2004,15(1):887-888. |
| [22] | Jordan O, Denys A, Baere T D . Comparative study of chemo-embolization loadable beads: in vitro drug release and physical properties of DC Bead and hepasphere loaded with doxorubicin and irinotecan[J]. J Vasc Interv Radiol, 2010,21(7):1084-1090. |
| [23] | Ahnfelt E, Sj?gren E, Axén N , et al. A miniaturized in vitro release method for investigating drug-release mechanisms[J]. Int J Pharm, 2015,486(1-2):339-349. |
| [24] | Gonzalez MV, Tang Y, Phillips GJ , et al. Doxorubicin eluting beads-2: methods for evaluating drug elution and in-vitro: in-vivo correlation[J]. J Mater Sci Mater Med, 2008,19(2):767-775. |
| [25] | Zhao Z, Li J, Yang Y , et al. Preparation and characterization of sunitinib-loaded microspheres for arterial embolization[J]. J Chin Pharm Sci, 2014,23(8):558-564. |
| [26] | Woo BH, Kostanski JW, Gebrekidan S , et al. Preparation, cha-racterization and in vivo evaluation of 120-day poly (d, l-lactide) leuprolide microspheres[J]. J Control Release, 2001,75(3):307-315. |
| [27] | Altekruse SF, Henley SJ, Cucinelli JE , et al. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States[J]. Am J Gastroenterol, 2014,109(4):542-553. |
| [28] | 姚红, 于雷, 钟丽华 , 等. DKK-1与肝脏恶性肿瘤的相关研究进展[J]. 现代生物医学进展, 2016,16(10):1962-1965. |
| [29] | Llovet JM, Bisceglie AMD, Bruix J , et al. Design and endpoints of clinical trials in hepatocellular carcinoma[J]. J Natl Cancer Inst, 2008,100(10):698-711. |
/
| 〈 |
|
〉 |